Skip to main content
. 2022 Jun 22;12:930647. doi: 10.3389/fonc.2022.930647

Figure 3.

Figure 3

ESPL1 knockdown inhibited cell migration and invasion of LUAD. (A, B) IHC assay used to determine the protein of ESPL1 in clinical lung cancer samples. (C) The relative expression of ESPL1 in LUAD cell lines including H1650, H358, A549, and H1299 examined by real-time RT-PCR and human bronchial epithelial (BEAS2B) cell line was used as control. (D) Establishment of ESPL1 knockdown in A549 and H1299 cells, verified by real-time RT-PCR. (E–H) Downregulation of ESPL1 inhibited A549 and H1299 cell migration and invasion by transwell and wound healing assays, Quantification data were also indicated for each assay. Scale bar = 50 μm. **p < 0.01; ***p < 0.001.